Back | Table of Contents | Abstract | PDF | Mail to Author |

Do Volume-Based and Metabolic 18F FDG PET/CT Parameters Identify Groups at Risk for Poor Prognosis in Patients with Newly Diagnosed Metastatic and Non-Metastatic Non-Small Cell Lung Cancer?

Osman KUPIK¹, Mehmet BOZKURT², Sertac ASA³, Gulnihan EREN⁴, Hasan Gundogdu⁵, Medeni ARPA<sup>6

1</sup>Recep Tayyip Erdoğan University- Faculty of Medicine, Department of Nuclear Medicine, Rize, TURKEY
²University of Health Sciences, Faculty of Medicine, Department of Nuclear Medicine, Istanbul, TURKEY
³Istanbul University-Cerrahpasa, Faculty of Medicine, Department of Nuclear Medicine, Istanbul, TURKEY
⁴University of Sıtkı Kocman, Faculty of Medicine, Department of Radiation Oncology, Muğla, TURKEY
⁵Recep Tayyip Erdoğan University, Faculty of Medicine, Department of Radiology, Rize, TURKEY
⁶Recep Tayyip Erdoğan University, Faculty of Medicine, Department of Biochemistry, Rize, TURKEY

---

Back | Table of Contents | Abstract | PDF | Mail to Author |